Orum Therapeutics
Latest round
- Series C
Last raised
- Jun 2021
Total raised
- $91M
Investors
- 14
About Orum Therapeutics
Founded in 2016 and based in Daejeon, South Korea, Orum Therapeutics, Inc. develops a cell-penetrating antibody platform targeting specific cell types for treating genetic diseases and cancers. In February 2025, Orum Therapeutics, Inc.5 million shares at KRW 20,000 apiece, below the expected price range of KRW 24,000 and KRW 30,000 on the KOSDAQ. Orum Therapeutics, Inc.
Who invested in Orum Therapeutics
14 investors across 3 rounds
See all investors in Orum Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Orum Therapeutics
Who invested in Orum Therapeutics?
Orum Therapeutics has 14 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Orum Therapeutics raised?
Orum Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Orum Therapeutics last raise money?
Orum Therapeutics's most recent round on record is a Series C, in Jun 2021.
What does Orum Therapeutics do?
Founded in 2016 and based in Daejeon, South Korea, Orum Therapeutics, Inc.
Where is Orum Therapeutics headquartered?
Orum Therapeutics is headquartered in Daejeon, South Korea.
Which VCs invest in companies like Orum Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Orum Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Orum Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.